A Closer Look at 7 Analyst Recommendations For Catalyst Pharmaceuticals
A Closer Look at 7 Analyst Recommendations For Catalyst Pharmaceuticals
分析師對catalyst pharmaceuticals的7個推薦做出更深入的研究
Catalyst Pharmaceuticals (NASDAQ:CPRX) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在過去的三個月中，Catalyst Pharmaceuticals (NASDAQ:CPRX) 已經被7位分析師進行了分析，展示出了從看好到看淡的不同觀點。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格總結了分析師們最近的評級，揭示了過去30天內情緒的變化並將其與前幾個月進行了比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $28.43, along with a high estimate of $34.00 and a low estimate of $23.00. Marking an increase of 7.98%, the current average surpasses the previous average price target of $26.33.
分析師提供了更深層次的見解，他們建立了12個月的目標價值，顯示平均目標價值爲28.43美元，最高價值爲34.00美元，最低價值爲23.00美元。當前的平均目標價值增加了7.98％，超過了以前的平均目標價值26.33美元。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級：詳細剖析
The perception of Catalyst Pharmaceuticals by financial...
通過最近的分析...
登入免費觀看全文
登入/註冊